Literature DB >> 10837804

Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells.

T Koppal1, T V Petrova, L J Van Eldik.   

Abstract

15-deoxy-Delta(12,14)-PGJ(2), a cyclopentenone derivative of PGD(2), was recently reported [Petrova et al., Proc. Natl. Acad. Sci. USA 96 (1999) 4668-4673] to suppress inducible nitric oxide synthase (iNOS) production in microglia and mixed glial cultures stimulated with lipopolysaccharide (LPS). We report here that in addition to suppressing iNOS production, 15d-PGJ(2) also decreases the production of tumor necrosis factor alpha (TNFalpha), interleukin-1 beta (IL-1beta) and cyclooxygenase-2 (COX-2) in LPS-stimulated BV-2 microglial cells, thereby acting as a general inhibitor of microglial activation. Concomitantly, 15d-PGJ(2) itself up-regulates the production of the antioxidant enzyme heme oxygenase-1 (HO-1) and increases intracellular total glutathione levels. To test if increased HO-1 levels were involved in the ability of 15d-PGJ(2) to block microglial activation, we used a HO-1 inhibitor that could block the activity of HO-1. The presence of the HO-1 inhibitor did not alter the 15d-PGJ(2)-induced inhibition of LPS-stimulated iNOS and TNFalpha protein levels, and led to only a partial reduction in the protection offered by 15d-PGJ(2) against LPS-induced nitrite production. These results suggest that HO-1 upregulation by 15d-PGJ(2) is not the primary pathway responsible for the anti-inflammatory action of 15d-PGJ(2) in microglial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837804     DOI: 10.1016/s0006-8993(00)02270-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats.

Authors:  Borja García-Bueno; José L M Madrigal; Ignacio Lizasoain; María A Moro; Pedro Lorenzo; Juan C Leza
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

2.  Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.

Authors:  Paul D Storer; Jihong Xu; Janet A Chavis; Paul D Drew
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

Review 3.  Hormone regulation of microglial cell activation: relevance to multiple sclerosis.

Authors:  Paul D Drew; Paul D Storer; Jihong Xu; Janet A Chavis
Journal:  Brain Res Brain Res Rev       Date:  2005-01-19

Review 4.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

5.  Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?

Authors:  Anna R Carta; Augusta Pisanu; Ezio Carboni
Journal:  Parkinsons Dis       Date:  2011-03-29

6.  Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction.

Authors:  Joo Yeun Oh; Niroshini Giles; Aimee Landar; Victor Darley-Usmar
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

Review 7.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

Review 8.  Redox control of microglial function: molecular mechanisms and functional significance.

Authors:  Ana I Rojo; Gethin McBean; Marina Cindric; Javier Egea; Manuela G López; Patricia Rada; Neven Zarkovic; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-05-05       Impact factor: 8.401

9.  Prevention of methylmercury-induced mitochondrial depolarization, glutathione depletion and cell death by 15-deoxy-delta-12,14-prostaglandin J(2).

Authors:  Jason Y Chang; Pao-Feng Tsai
Journal:  Neurotoxicology       Date:  2008-08-19       Impact factor: 4.294

10.  Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression.

Authors:  D Martin Watterson; Anastasia V Velentza; Magdalena Zasadzki; Jeffrey M Craft; Jacques Haiech; Linda J Van Eldik
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.